Change in Platelet Lipid Metabolism and Procoagulant Phenotype Induced by Cardiopulmonary Bypass. Impact on Postoperative Inflammatory Response and Bleeding Complications During Cardiac Surgery.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversité Catholique de Louvain

About this trial

The PLACARD research project aims to investigate the impact of CPB-induced platelet modifications during cardiac surgery on the post-operative inflammatory response and bleeding complications. Our objectives are to study the impact of CPB on the formation of procoagulant platelets, to assess changes in platelet lipid profile and bioenergetics before, during and after cardiac surgery, and to connect the ex-vivo observations to post-operative clinical and biological parameters of these patients during their stay in cardiovascular intensive care unit.

Eligibility criteria

Qualifiers

Adult patients (≥ 18 years old) suffering from coronary disease and/or severe valvular dysfunction (mitral or aortic) undergoing elective coronary angiography or cardiac surgery with cardiopulmonary bypass.

Disqualifiers

Uninterrupted preoperative dual antiplatelet therapy

Active chronic inflammatory disease

Recent chemotherapy or immunotherapy (< 3 months)

Active solid malignancy

Trial design

Treatments tested in this trial

  • Arterial blood sample
  • Arterial blood sample

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Université Catholique de Louvain

Lead sponsor

Fonds National de la Recherche Scientifique

Collaborator

Fondation Mont-Godinne

Collaborator